Evolutionary trajectories of primate genes involved in HIV pathogenesis

Molecular Biology and Evolution

Volumn 26, Issue 12, 2009, Pages 2865-2875

  Ortiz, Millán ^a   Guex, Nicolas ^b   Patin, Etienne ^c   Martin, Olivier ^b   Xenarios, Ioannis ^b   Ciuffi, Angela ^a   Quintana Murci, Lluís ^d   Telenti, Amalio ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b SWISS INSTITUTE OF BIOINFORMATICS   (Switzerland)

^c IMAGINE INSTITUTE   (France)

^d CNRS   (France)

Author keywords

APOBEC3; Evolutionary genomics; HapMap; Tetherin; TRIM5

Indexed keywords

ADAM PROTEIN; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3H; CD4 ANTIGEN; CD45 ANTIGEN; CHEMOKINE RECEPTOR CXCR1; INTERLEUKIN 4; PROTEIN; PROTEIN CLEC4M; PROTEIN DEFB1; PROTEIN GML; PROTEIN KINASE B; STROMAL CELL DERIVED FACTOR 1; TETHERIN; TOLL LIKE RECEPTOR 7; TRIPARTITE MOTIF PROTEIN 5; UNCLASSIFIED DRUG;

ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EVOLUTION; GENE SEQUENCE; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN GENETICS; HUMAN IMMUNODEFICIENCY VIRUS 1; INFECTION SENSITIVITY; INNATE IMMUNITY; MACACA; NONHUMAN; PRIMATE; SINGLE NUCLEOTIDE POLYMORPHISM; SPECIES DIFFERENCE; VIRUS PATHOGENESIS;

ANIMALS; CODON; EVOLUTION, MOLECULAR; HIV; HIV INFECTIONS; HUMANS; PRIMATES; PROTEIN STRUCTURE, TERTIARY; PROTEINS; SELECTION, GENETIC; SEQUENCE ALIGNMENT; SUBCELLULAR FRACTIONS;

CALLITHRIX JACCHUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MACACA MULATTA; PAN TROGLODYTES; PONGO PYGMAEUS ABELII; PRIMATES;

EID: 70549093003     PISSN: 07374038     EISSN: 15371719     Source Type: Journal    
DOI: 10.1093/molbev/msp197     Document Type: Article

References (61)

1. Barr SD, Smiley JR, Bushman FD. 2008. The interferon response inhibits HIV particle production by induction of TRIM22. PLoS Pathog. 4:e1000007.
2. Barreiro LB, Laval G, Quach H, Patin E, Quintana-Murci L. 2008. Natural selection has driven population differentiation in modern humans. Nat Genet. 40:340-345.
3. Bashirova AA, Wu L, Cheng J, Martin TD, Martin MP, Benveniste RE, Lifson JD, Kewalramani VN, Hughes A, Carrington M. 2003. Novel member of the CD209 (DC-SIGN) gene family in primates. J Virol. 77:217-227.
4. Borgatti P, Zauli G, Colamussi ML, Gibellini D, Previati M, Cantley LL, Capitani S. 1997. Extracellular HIV-1 Tat protein activates phosphatidylinositol-3 and Akt/PKB kinases in CD4 T lymphoblastoid Jurkat cells. Eur J Immunol. 27: 2805-2811.
5. Brass AL, Dykxhoorn DM, Benita Y, Yan N, Engelman A, Xavier RJ, Lieberman J, Elledge SJ. 2008. Identification of host proteins required for HIV infection through a functional genomic screen. Science. 319:921-926.
6. Bushman FD, Malani N, Fernandes J, et al. (17 co-authors). 2009. Host cell factors in HIV replication: meta-analysis of genome-wide studies. PLoS Pathog. 5:e1000437.
7. Bustamante CD, Fledel-Alon A, Williamson S, et al. (14 coauthors). 2005. Natural selection on protein-coding genes in the human genome. Nature. 437:1153-1157.
8. Calderwood MA, Venkatesan K, Xing L, et al. (13 coauthors). 2007. Epstein-Barr virus and virus human protein interaction maps. Proc Natl Acad Sci USA. 104: 7606-7611.
9. Chimpanzee Sequencing and Analysis Consortium. 2005. Initial sequence of the chimpanzee genome and comparison with the human genome. Nature. 437:69-87.
10. Clark AG, Glanowski S, Nielsen R, et al. (17 co-authors). 2003. Inferring nonneutral evolution from human-chimp-mouse orthologous gene trios. Science. 302:1960-1963.
11. Coop G, Pickrell JK, Novembre J, Kudaravalli S, Li J, Absher D, Myers RM, Cavalli-Sforza LL, Feldman MW, Pritchard JK. 2009. The role of geography in human adaptation. PLoS Genet. 5:e1000500.
12. Del PM, Boniotto M, Zuccon D, Cervella P, Spano A, Amoroso A, Crovella S. 2002. Beta-defensin 1 gene variability among non-human primates. Immunogenetics. 53:907-913.
13. Edgar RC. 2004. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res. 32:1792-1797.
14. Esnault C, Heidmann O, Delebecque F, Dewannieux M, Ribet D, Hance AJ, Heidmann T, Schwartz O. 2005. APOBEC3G cytidine deaminase inhibits retrotransposition of endogenous retroviruses. Nature. 433:430-433.
15. Fellay J, Shianna KV, Ge D, et al. (27 co-authors). 2007. A whole-genome association study of major determinants for host control of HIV-1. Science. 317:944-947.
16. Goff SP, 2007. Host factors exploited by retroviruses. Nat Rev Microbiol. 5:253-263.
17. Goldschmidt V, Ciuffi A, Ortiz M, Brawand D, Munoz M, Kaessmann H, Telenti A. 2008. Antiretroviral activity of ancestral TRIM5alpha. J Virol. 82:2089-2096.
18. Goodman M, 1999. The genomic record of Humankind's evolutionary roots. Am J Hum Genet. 64:31-39.
19. Gupta RK, Hue S, Schaller T, Verschoor E, Pillay D, Towers GJ. 2009. Mutation of a single residue renders human tetherin resistant to HIV-1 Vpu-mediated depletion. PLoS Pathog. 5:e1000443.
20. Harris RS, Liddament MT. 2004. Retroviral restriction by APOBEC proteins. Nat Rev Immunol. 4:868-877.
21. Hartshorn KL, Liou LS, White MR, Kazhdan MM, Tauber JL, Tauber AI. 1995. Neutrophil deactivation by influenza A virus. Role of hemagglutinin binding to specific sialic acid-bearing cellular proteins. J Immunol. 154:3952-3960.
22. Hebert CA, Chuntharapai A, Smith M, Colby T, Kim J, Horuk R. 1993. Partial functional mapping of the human interleukin-8 type A receptor. Identification of a major ligand binding domain. J Biol Chem. 268:18549-18553.
23. Kaiser SM, Malik H, Emerman M. 2007. Restriction of an extinct retrovirus by the human TRIM5 alpha antiviral protein. Science. 316:1756-1758.
24. Kent WJ, 2002. BLAT-the BLAST-like alignment tool. Genome Res. 12:656-664.
25. Kidd JM, Newman TL, Tuzun E, Kaul R, Eichler EE. 2007. Population stratification of a common APOBEC gene deletion polymorphism. PLoS Genet. 3:e63.
26. Konig R, Zhou Y, Elleder D, et al. (22 co-authors). 2008. Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. Cell. 135:49-60.
27. Kosiol C, Vinar T, da Fonseca RR, Hubisz MJ, Bustamante CD, Nielsen R, Siepel A. 2008. Patterns of positive selection in six mammalian genomes. PLoS Genet. 4:e1000144.
28. Kudaravalli S, Veyrieras JB, Stranger BE, Dermitzakis ET, Pritchard JK. 2009. Gene expression levels are a target of recent natural selection in the human genome. Mol Biol Evol. 26:649-658.
29. Kwong PD, Wyatt R, Robinson J, Sweet RW, Sodroski J, Hendrickson WA. 1998. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature. 393:648-659.
30. Loeuillet C, Deutsch S, Ciuffi A, Robyr D, Taffe P, Munoz M, Beckmann JS, Antonarakis SE, Telenti A. 2008. In vitro whole-genome analysis identifies a susceptibility locus for HIV-1. PLoS Biol. 6:e32.
31. Loytynoja A, Goldman N. 2008. Phylogeny-aware gap placement prevents errors in sequence alignment and evolutionary analysis. Science. 320:1632-1635.
32. McNatt MW, Zang T, Hatziioannou T, Bartlett M, Fofana IB, Johnson WE, Neil SJ, Bieniasz PD. 2009. Species-specific activity of HIV-1 Vpu and positive selection of tetherin transmembrane domain variants. PLoS Pathog. 5:e1000300.
33. Neil SJ, Zang T, Bieniasz PD. 2008. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature. 451: 425-430.
34. Nisole S, Stoye JP, Saib A. 2005. TRIM family proteins: retroviral restriction and antiviral defence. Nat Rev Microbiol. 3:799-808.
35. OhAinle M, Kerns JA, Malik HS, Emerman M. 2006. Adaptive evolution and antiviral activity of the conserved mammalian cytidine deaminase APOBEC3H. J Virol. 80:3853-3862.
36. Ortiz M, Bleiber G, Martinez R, Kaessmann H, Telenti A. 2006. Patterns of evolution of host proteins involved in retroviral pathogenesis. Retrovirology. 3:11.
37. Ortiz M, Kaessmann H, Zhang K, Bashirova A, Carrington M, Quintana-Murci L, Telenti A. 2008. The evolutionary history of the CD209 (DC-SIGN) family in humans and non-human primates. Genes Immun. 9:483-492.
38. Perez-Caballero D, Soll SJ, Bieniasz PD. 2008. Evidence for restriction of ancient primate gammaretroviruses by APO-BEC3 but not TRIM5alpha proteins. PLoS Pathog. 4: e1000181.
39. Quintana-Murci L, Alcais A, Abel L, Casanova JL. 2007. Immunology in natura: clinical, epidemiological and evolutionary genetics of infectious diseases. Nat Immunol. 8: 1165-1171.
40. Rice P, Longden I, Bleasby A. 2000. EMBOSS: the European Molecular Biology Open Software Suite. Trends Genet. 16:276-277.
41. Rockman MV, Hahn MW, Soranzo N, Goldstein DB, Wray GA. 2003. Positive selection on a human-specific transcription factor binding site regulating IL4 expression. Curr Biol. 13:2118-2123.
42. Sabeti PC, Schaffner SF, Fry B, Lohmueller J, Varilly P, Shamovsky O, Palma A, Mikkelsen TS, Altshuler D, Lander ES. 2006. Positive natural selection in the human lineage. Science. 312:1614-1620.
43. Sabeti PC, Varilly P, Fry B, et al. (12 co-authors), and, The International HapMap Consortium. 2007. Genome-wide detection and characterization of positive selection in human populations. Nature. 449:913-918.
44. Sawyer SL, Emerman M, Malik HS. 2004. Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G. PLoS Biol. 2:E275.
45. Sawyer SL, Emerman M, Malik HS. 2007. Discordant evolution of the adjacent antiretroviral genes TRIM22 and TRIM5 in mammals. PLoS Pathog. 3:e197.
46. Sawyer SL, Wu LI, Emerman M, Malik HS. 2005. Positive selection of primate TRIM5{alpha} identifies a critical species-specific retroviral restriction domain. Proc Natl Acad Sci USA. 102:2832-2837.
47. Sheehy AM, Gaddis NC, Choi JD, Malim MH. 2002. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature. 418:646-650.
48. Stranger BE, Forrest MS, Dunning M, et al. (17 co-authors). 2007. Relative impact of nucleotide and copy number variation on gene expression phenotypes. Science. 315: 848-853.
49. Stremlau M, Owens CM, Perron MJ, Kiessling M, Autissier P, Sodroski J. 2004. The cytoplasmic body component TRI-M5alpha restricts HIV-1 infection in Old World monkeys. Nature. 427:848-853.
50. Swanson CM, Malim MH. 2008. SnapShot: HIV-1 proteins. Cell. 133:742.
51. Tchilian EZ, Wallace DL, Dawes R, Imami N, Burton C, Gotch F, Beverley PC. 2001. A point mutation in CD45 may be associated with an increased risk of HIV-1 infection. AIDS. 15:1892-1894.
52. Telenti A. Forthcoming 2009. HIV-1 host interactions-integration of large scale datasets. F1000 Biology Reports.
53. Voight BF, Kudaravalli S, Wen X, Pritchard JK. 2006. A map of recent positive selection in the human genome. PLoS Biol. 4:e72.
54. Wagner A. 2007. Rapid detection of positive selection in genes and genomes through variation clusters. Genetics. 176:2451-2463.
55. Whiteman EL, Cho H, Birnbaum MJ. 2002. Role of Akt/protein kinaseBinmetabolism.Trends Endocrinol Metab. 13:444-451.
56. Yang Z. 1997. PAML: a program package for phylogenetic analysis by maximum likelihood. Comput Appl Biosci. 13: 555-556.
57. Yang Z, Bielawski JP. 2000. Statistical methods for detecting molecular adaptation. Trends Ecol Evo. 15:496-503.
58. Yang Z, Nielsen R, Goldman N, Pedersen AM. 2000. Codon-substitution models for heterogeneous selection pressure at amino acid sites. Genetics. 155:431-449.
59. Yang Z, Wong WS, Nielsen R. 2005. Bayes empirical Bayes inference of amino acid sites under positive selection. Mol Biol Evol. 22:1107-1118.
60. Zhang ZD, Weinstock G, Gerstein M. 2008. Rapid evolution by positive Darwinian selection in T-cell antigen CD4 in primates. J Mol Evol. 66:446-456.
61. Zhou H, Xu M, Huang Q, et al. (11 co-authors). 2008. Genome-scale RNAi screen for host factors required for HIV replication. Cell Host Microbe. 4:495-504.